CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoARCADIPANE, FRANCESCA
Dettaglio
ARCADIPANE, FRANCESCA
Pubblicazioni
Risultati 1 - 20 di 35 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Biochemical and clinical outcomes after high-dose salvage radiotherapy as monotherapy for prostate cancer. | 2014 | Botticella A;Guarneri A;Levra NG;Munoz F;Filippi AR;Rondi N;Badellino S;Arcadipane F;Levis M;Ragona R;Ricardi U |
| 2 | Bone Marrow-Sparing IMRT in Anal Cancer Patients Undergoing Concurrent Chemo-Radiation: Results of the First Phase of a Prospective Phase II Trial | 2020 | Francesca Arcadipane, Patrick Silvetti, Francesco Olivero, Alessio Gastino, Viola De Luca, Massimiliano Mistrangelo, Paola Cassoni, Patrizia Racca, Elena Gallio, Adriana Lesca, Christian Fiandra, Umberto Ricardi, Pierfrancesco Franco |
| 3 | Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study. | 2018 | FRANCO PIERFRANCESCO, DE BARI BERARDINO, ARCADIPANE FRANCESCA, ALEXIS LEPINOY, MANUELA CECCARELLI, GABRIELLA FURFARO, MISTRANGELO MASSIMILIANO, CASSONI PAOLA, VALGIUSTI MARTINA, PASSARDI ALESSANDRO, CASADEI GARDINI ANDREA, TRINO ELISABETTA, MARTINI STEFANIA, IORIO GIUSEPPE CARLO, EVANGELISTA ANDREA, RICARDI UMBERTO, CREHANGE GILLES |
| 4 | Concurrent chemoradiation in anal cancer patients delivered with bone marrow-sparing imrt: Final results of a prospective phase ii trial | 2021 | Arcadipane F.; Silvetti P.; Olivero F.; Gastino A.; Carlevato R.; Chiovatero I.; Spinelli L.; Mistrangelo M.; Cassoni P.; Ritorto G.; Gallio E.; Lesca A.; Faletti R.; Giglioli F.R.; Fiandra C.; Ricardi U.; Franco P. |
| 5 | Decreasing treatment burden in HPV-related OPSCC: A systematic review of clinical trials | 2021 | Iorio G.C.; Arcadipane F.; Martini S.; Ricardi U.; Franco P. |
| 6 | Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation | 2018 | Franco, Pierfrancesco; Arcadipane, Francesca; Ragona, Riccardo; Lesca, Adriana; Gallio, Elena; Mistrangelo, Massimiliano; Trino, Elisabetta; Cassoni, Paola; Arena, Vincenzo; Baccega, Massimo; Racca, Patrizia; Faletti, Riccardo; Rondi, Nadia; Morino, Mario; Ricardi, Umberto |
| 7 | Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients | 2016 | Franco, Pierfrancesco; Arcadipane, Francesca; Ragona, Riccardo; Lesca, Adriana; Gallio, Elena; Mistrangelo, Massimiliano; Cassoni, Paola; Arena, Vincenzo; Bustreo, Sara; Faletti, Riccardo; Rondi, Nadia; Morino, Mario; Ricardi, Umberto |
| 8 | Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer | 2017 | Franco, P; Ragona, R.; Arcadipane, F.; Mistrangelo, M.; Cassoni, P.; Rondi, N.; Morino, M.; Racca, P.; Ricardi, U. |
| 9 | Early-stage Node-negative (T1-T2N0) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy | 2016 | Franco, Pierfrancesco; Arcadipane, Francesca; Ragona, Riccardo; Mistrangelo, Massimiliano; Cassoni, Paola; Rondi, Nadia; Morino, Mario; Racca, Patrizia; Ricardi, Umberto |
| 10 | Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective | 2017 | Franco, Pierfrancesco; Arcadipane, Francesca; Ragona, Riccardo; Mistrangelo, Massimiliano; Cassoni, Paola; Racca, Patrizia; Morino, Mario; Numico, Gianmauro; Ricardi, Umberto |
| 11 | Hypofractionation with no boost after breast conservation in early-stage breast cancer patients | 2016 | Arcadipane, Francesca; Franco, Pierfrancesco; De Colle, Chiara; Rondi, Nadia; Di Muzio, Jacopo; Pelle, Emanuela; Martini, Stefania; Ala, Ada; Airoldi, Mario; Donadio, Michela; De Sanctis, Corrado; Castellano, Isabella; Ragona, Riccardo; Ricardi, Umberto |
| 12 | Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer | 2018 | Arcadipane, Francesca; Franco, Pierfrancesco; Ceccarelli, Manuela; Furfaro, Gabriella; Rondi, Nadia; Trino, Elisabetta; Martini, Stefania; Iorio, Giuseppe Carlo; Mistrangelo, Massimiliano; Cassoni, Paola; Racca, Patrizia; Morino, Mario; Ricardi, Umberto |
| 13 | Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier) | 2019 | Casadei-Gardini, Andrea; Montagnani, Francesco; Casadei, Chiara; Arcadipane, Francesca; Andrikou, Kalliopi; Aloi, Deborah; Prete, Alessandra Anna; Zampino, Maria Giulia; Argentiero, Antonella; Pugliese, Giuseppe; Martini, Stefania; Iorio, Giuseppe Carlo; Scartozzi, Mario; Mistrangelo, Massimiliano; Fornaro, Lorenzo; Cassoni, Paola; Marisi, Giorgia; Dell'Acqua, Veronica; Ravenda, Paola Simona; Lonardi, Sara; Silvestris, Nicola; De Bari, Berardino; Ricardi, Umberto; Cascinu, Stefano; Franco, Pierfrancesco |
| 14 | Incorporating18FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation | 2017 | Franco, Pierfrancesco*; Fiandra, Christian; Arcadipane, Francesca; Trino, Elisabetta; Giglioli, Francesca Romana; Ragona, Riccardo; Ricardi, Umberto |
| 15 | Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series | 2015 | Franco, Pierfrancesco; Mistrangelo, Massimiliano; Arcadipane, Francesca; Munoz, Fernando; Sciacero, Piera; Spadi, Rosella; Migliaccio, Fernanda; Angelini, Veronica; Bombaci, Sebastiano; Rondi, Nadia; Numico, Gianmauro; Ragona, Riccardo; Cassoni, Paola; Morino, Mario; Racca, Patrizia; Ricardi, Umberto |
| 16 | Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy | 2016 | Franco, Pierfrancesco; Arcadipane, Francesca; Ragona, Riccardo; Mistrangelo, Massimiliano; Cassoni, Paola; Rondi, Nadia; Morino, Mario; Racca, Patrizia; Ricardi, Umberto |
| 17 | Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation | 2016 | Franco, Pierfrancesco; Ragona, Riccardo; Arcadipane, Francesca; Mistrangelo, Massimiliano; Cassoni, Paola; Rondi, Nadia; Morino, Mario; Racca, Patrizia; Ricardi, Umberto |
| 18 | Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients | 2017 | Franco, Pierfrancesco; Rampino, Monica; Ostellino, Oliviero; Schena, Marina; Pecorari, Giancarlo; Garzino Demo, Paolo; Fasolis, Massimo; Arcadipane, Francesca; Martini, Stefania; Cavallin, Chiara; Airoldi, Mario; Ricardi, Umberto |
| 19 | Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials | 2017 | Franco, Pierfrancesco; Arcadipane, Francesca; Strignano, Paolo; Spadi, Rosella; Trino, Elisabetta; Martini, Stefania; Iorio, Giuseppe Carlo; Satolli, Maria Antonietta; Airoldi, Mario; Romagnoli, Renato; Camandona, Michele; Ricardi, Umberto |
| 20 | The prognostic role of hemoglobin levels in patients undergoing concurrent chemo-radiation for anal cancer | 2018 | Franco, Pierfrancesco; Montagnani, Francesco; Arcadipane, Francesca; Casadei, Chiara; Andrikou, Kalliopi; Martini, Stefania; Iorio, Giuseppe Carlo; Scartozzi, Mario; Mistrangelo, Massimiliano; Fornaro, Lorenzo; Cassoni, Paola; Cascinu, Stefano; Ricardi, Umberto; Casadei Gardini, Andrea |
Copyright © 2022